Generics - Pharmaceutical


Current filters:


Popular Filters

76 to 100 of 470 results

Mylan strikes deal for Parkinson's disease drug Stalevo


US generics firm Mylan (Nasdaq: MYL) and Finland-based drugmaker Orion Corp (Nasdaq OMX Helsinki: ORNAV)…

GenericsLicensingMylan LaboratoriesNeurologicalNorth AmericaOrion CorpPharmaceuticalStalevo

Recordati acquires Tunisian drugmaker


Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

US FTC will continue to challenge "anticompetitive" pharma pay-for-delay deals


The Federal Trade Commission told a Senate Judiciary subcommittee yesterday (July 23) that it will continue…

GenericsLegalLicensingMarkets & MarketingNorth AmericaPharmaceutical

Patent settlement curbs could reduce incentives to bring generics to market; report


A new white paper released this week, titled The Benefits of Patent Settlements: New Survey Evidence…

GenericsNorth AmericaPatentsPharmaceutical

Forest agrees another license deal for Bystolic


US drugmaker Forest Laboratories (NYSE:FRX) and Forest Laboratories Holdings have reached a settlement…

Amerigen PharmaceuticalsBystolicCardio-vascularForest LaboratoriesGenericsLicensingNorth AmericaPharmaceutical

Lupin to market MSD vaccine in India


US pharma giant Merck & Co (NYSE: MRK), known as MSD outside of North America, has entered into an India…


Eternity and PharmaNova to develop branded medicines


Canadian medical device company Eternity Healthcare (OTC:ETAH) has signed a letter of intent with privately-held…

Eternity HealthcareGenericsMetabolicsPharmaceuticalPharmaNovaResearch

Mylan victorious in patent dispute with Teva


US generic drugmaker Mylan (Nasdaq: MYL) says that Israel-based Teva Pharmaceuticals Industries (NYSE:…

GenericsMylan LaboratoriesNorth AmericaPatentsPerforomistPharmaceuticalTeva Pharmaceutical Industries

Novartis 2nd-quarter in line with analysts' forecasts


Novartis 2nd-quarter in line with analysts' forecasts


Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms


Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating…


Less than 30% of drugs in Nigeria made locally


Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

New Zealand approves proposals diazepam, gabapentin and naltrexone listing


New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of proposals relating…


Statin drugs save health care systems money as well as saving lives, UK study shows


Statins not only help save lives but are great value for money too, even in lower risk patients, according…


Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma


Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

US pharma patent settlements netted $25.5 billion in savings for health system; report


Generic pharmaceuticals launched prior to patent expiration due to a patent settlement - also called…

FinancialGenericsNorth AmericaPatentsPharmaceutical

FDA plans to revise drug labeling regulations by September


The US Food and Drug Administration says it plans to issue a proposed rule to revise FDA regulations…

GenericsNorth AmericaPharmaceuticalRegulation

Indian pharma threatened by trend of shifting R&D operations overseas: survey


Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma


In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards


From July 2, 2013, all active substances manufactured outside of the European Union and imported into…


Azerbaijan looks set to be a growing player in health care industry


The young but rapidly growing oil-rich Azerbaijan, which gained independence from the Soviet Union in…

EuropeGenericsHealthcareMarkets & MarketingPharmaceutical

76 to 100 of 470 results

Back to top